It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products
Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
YOU MIGHT ALSO LIKE
Bilzin Sumberg is pleased to announce that Construction Law & Litigation Practice Group Leader Joy Spillis Lundeen has been recognized by GlobeSt., a leading commercial real estate news and information platform, as one of its 2026 "Women of Influence."
Bilzin Sumberg is pleased to announce that Public-Private Partnerships and Government Contracting Partner Diana C. Mendez has been appointed a Council Member of the American Bar Association (ABA) Public Contract Law Section.
Bilzin Sumberg is pleased to announce that Chief Executive Officer and Managing Partner Albert E. Dotson, Jr. has been recognized among Florida Trend Magazine's 2026 Legal Elite: NOTABLE Managing Partners, for the fourth consecutive year.
